课件参考2015 asco会议会议109833_slide.pptxVIP

Impact of Neoadjuvant Therapy on Breast Conservation Rates in HER2-Positive and Triple-Negative Breast Cancer: Combined Results of: CALGB 40601 and 40603 br /;Objectives;NSABP B-18br /Neoadjuvant vs. Adjuvant AC;Randomized Trials of Neoadjuvant vs. Adjuvant Therapy in Breast Cancer;Slide 5;Pathologic Complete Response Correlates Withbr /Event-Free Survival;Slide 7;Slide 8;Slide 9;Slide 10;CALGB 40601/40603: Surgical Methods;Slide 12;Slide 13;Slide 14;Slide 15;Slide 16;Slide 17;Slide 18;Slide 19;Slide 20;Summary Results;Slide 22;Conclusions;Acknowledgments;Slide 25